Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
ASCO 2023 - Breast Cancer
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
ASCO 2023 - Breast Cancer
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
2023
2022
2021
2020
ESMO Early Breast Cancer
ESR1-Targeted Therapy
Relapsed/Refractory Follicular Lymphoma
PET/CT Imaging in Prostate Cancer Patients
NTRK
Gene Fusions
Ovarian Cancer Series
Results from the OSPREY Trial in Pre-Prostatectomy Patients
Interview with the Innovators
PET/CT Imaging in Prostate Cancer Patients
Videos
Steven Rowe, MD, PhD
Radiology and Radiological Science
Johns Hopkins Medicine,
Baltimore, MD
Dr Steven Rowe continues his discussion of PYLARIFY
®
(piflufolastat F 18) imaging, with a focus on results from the OSPREY clinical trial in pre-prostatectomy patients.
Related Items
Patients Are at the Heart of Everything We Do
January 2024, Vol 14, No 1
Interview with the Innovators
Evolving Adjuvant Treatment Landscape for HR+/HER2- Early Breast Cancer
By
Nadia Harbeck, MD, PhD
Videos
Interview with the Innovators
New Developments on Prognostic Markers for Patients With Early Breast Cancer
By
Nadia Harbeck, MD, PhD
Videos
Interview with the Innovators
Recent Clinical Trials of Neoadjuvant Immunotherapy in Breast Cancer
By
Nadia Harbeck, MD, PhD
Videos
Interview with the Innovators